目的:评价半导体激光经巩膜睫状体光凝术治疗难治性青光眼的效果。方法:回顾性分析55例56眼难治性青光眼的临床资料,均行睫状体光凝,术后随访观察并记录眼压、视力、眼部自觉症状以及并发症,随访时间3mo以上。结果:术前平均眼压53.5±18.7mmHg,末次随访平均眼压为19.4±9.6mmHg,术后眼压与术前眼压相比,差别具有统计学意义(P<0.01)。术后44眼视力无变化,2眼视力提高,10眼视力下降;眼痛均消失或缓解;并发症少,主要有葡萄膜炎、前房出血等。结论:睫状体光凝能有效降低难治性青光眼患者的眼压,且并发症少。

AIM:To evaluate the effect of diode laser transscleral cyclophotocoagulation(DL Tscpc) for refractory glaucoma.METHODS:Retrospective analysis was made in 55 patients(56 eyes) with refractory glaucoma who treated by DL Tscpc.Intraocular pressure(IOP),visual acuity,ocular symptoms and complications were observed after DL Tscpc.Patients were followed up over 3 months.RESULTS:Mean preoperative IOP was 53.5±18.7mmHg which was significantly different from the final follow-up mean IOP 19.4±9.6mmHg(P<0.01).Postoperative visual acuity remained unchanged in 44 eyes;improved in 2 eyes and decreased in 10 eyes.The pain sense disappeared or remarkably relieved.The main complications included uveitis and hyphema,etc.CONCLUSION:DL Tscpc is a simple,safe and effective therapy for eyes with refractory glaucoma.

R779.6